Stronger MS drugs did not curb relapse-free worsening
Key Takeaway
Stronger MS treatments did not reduce worsening that happened without a relapse or new changes on brain scans.
What They Found
Researchers compared stronger and moderately effective MS treatments using a French registry. Worsening without a relapse or new changes on brain scans happened slightly sooner in the stronger-treatment group. Other disability worsening tended to happen later in that group, though the difference was uncertain. Worsening linked to relapses or scan changes happened sooner in the moderate-treatment group. Older age, greater disability, and spots of damage in the spinal cord were linked to more worsening without disease activity.
Who Should Care and Why
The study included people whose MS began with relapses. All had started either a stronger or a moderately effective treatment. The findings concern disability worsening even when relapses and brain scans show no new activity. They also show that treatment groups can differ depending on which kind of worsening researchers measure. The study did not compare individual MS drugs.
Important Considerations
This was an observational study of 10,499 people, so it cannot prove that treatment choice caused the differences. People were followed for about 3.7 years on average. The abstract says the effect of stronger treatments on worsening without disease activity remains unclear.
AI-generated summary — for informational purposes only, not medical advice
Categories:
Article Topics:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel
Read More
10/7/2026
A 3D-printed immune implant eased advanced MS-like disease in mice without broadly weakening immunit
Read More
10/6/2026
Researchers found immune cells that swap surface tags in MS. An MS treatment removed them in the stu
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Brain : a journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.